SOTERA HEALTH COMPANY Financing Cash Flow
SOTERA HEALTH COMPANY (SHC) reported Financing Cash Flow of -$15.18 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- SOTERA HEALTH COMPANY net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$2.40M.
- SOTERA HEALTH COMPANY net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$12.78M.
- SOTERA HEALTH COMPANY net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$8.18M.
- SOTERA HEALTH COMPANY net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$77.34M.
- SOTERA HEALTH COMPANY net cash provided by (used in) financing activities for fiscal 2025 was -$100.53M.
- SOTERA HEALTH COMPANY net cash provided by (used in) financing activities for fiscal 2024 was -$50.56M, a 119.01% decline from fiscal 2023.
- SOTERA HEALTH COMPANY net cash provided by (used in) financing activities for fiscal 2023 was $265.96M, a 34.49% increase from fiscal 2022.
- SOTERA HEALTH COMPANY net cash provided by (used in) financing activities for fiscal 2022 was $197.76M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$15.18M 10-Q · filed 2026-08-06 | -$23.36M derived: sum of 3 quarters · filed 2026-08-06 | -$100.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$12.78M 10-Q · filed 2026-05-05 | -$20.95M derived: sum of 2 quarters · filed 2026-05-05 | -$98.29M derived: sum of 3 quarters · filed 2026-05-05 | -$105.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$8.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$85.51M derived: sum of 2 quarters · filed 2026-02-24 | -$92.45M derived: sum of 3 quarters · filed 2026-08-06 | -$100.53M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$77.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$84.27M derived: sum of 2 quarters · filed 2026-08-06 | -$92.36M 10-Q · filed 2025-11-04 | -$98.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$6.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$15.02M 10-Q · filed 2026-08-06 | -$21.57M derived: sum of 3 quarters · filed 2026-08-06 | -$24.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$8.09M 10-Q · filed 2026-05-05 | -$14.63M derived: sum of 2 quarters · filed 2026-05-05 | -$17.29M derived: sum of 3 quarters · filed 2026-05-05 | -$46.71M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$9.20M derived: sum of 2 quarters · filed 2026-02-24 | -$38.62M derived: sum of 3 quarters · filed 2026-02-24 | -$50.56M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$32.08M derived: sum of 2 quarters · filed 2025-11-04 | -$44.02M 10-Q · filed 2025-11-04 | -$47.81M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$29.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$41.36M 10-Q · filed 2025-08-08 | -$45.16M derived: sum of 3 quarters · filed 2026-02-24 | -$48.61M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$11.94M 10-Q · filed 2025-05-01 | -$15.73M derived: sum of 2 quarters · filed 2026-02-24 | -$19.19M derived: sum of 3 quarters · filed 2026-02-24 | -$19.90M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$7.25M derived: sum of 2 quarters · filed 2026-02-24 | -$7.96M derived: sum of 3 quarters · filed 2026-02-24 | $265.96M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$3.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$4.16M derived: sum of 2 quarters · filed 2024-11-05 | $269.75M 10-Q · filed 2024-11-05 | $469.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$710.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $273.21M 10-Q · filed 2024-08-05 | $472.45M derived: sum of 3 quarters · filed 2025-02-27 | $472.05M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $273.92M 10-Q · filed 2024-05-02 | $473.16M derived: sum of 2 quarters · filed 2025-02-27 | $472.76M derived: sum of 3 quarters · filed 2025-02-27 | $472.13M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $199.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $198.84M derived: sum of 2 quarters · filed 2025-02-27 | $198.21M derived: sum of 3 quarters · filed 2025-02-27 | $197.76M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$1.03M derived: sum of 2 quarters · filed 2023-11-01 | -$1.48M 10-Q · filed 2023-11-01 | -$3.27M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$634.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.08M 10-Q · filed 2023-08-03 | -$2.87M derived: sum of 3 quarters · filed 2024-02-27 | -$106.28M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$449.00K 10-Q · filed 2023-05-03 | -$2.23M derived: sum of 2 quarters · filed 2024-02-27 | -$105.64M derived: sum of 3 quarters · filed 2024-02-27 | -$113.95M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$105.20M derived: sum of 2 quarters · filed 2024-02-27 | -$113.50M derived: sum of 3 quarters · filed 2024-02-27 | -$117.29M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$103.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$111.72M derived: sum of 2 quarters · filed 2022-11-02 | -$115.50M 10-Q · filed 2022-11-02 | -$126.03M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$8.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$12.09M 10-Q · filed 2022-08-04 | -$22.62M derived: sum of 3 quarters · filed 2023-02-28 | $67.86M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$3.78M 10-Q · filed 2022-05-05 | -$14.31M derived: sum of 2 quarters · filed 2023-02-28 | $76.17M derived: sum of 3 quarters · filed 2023-02-28 | $20.34M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$10.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $79.95M derived: sum of 2 quarters · filed 2023-02-28 | $24.13M derived: sum of 3 quarters · filed 2023-02-28 | $73.43M 10-K · filed 2023-02-28 |
| 2020-09-30 | $90.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $34.65M derived: sum of 2 quarters · filed 2021-11-10 | $83.96M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$55.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$6.52M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $49.31M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$126.03M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |